Vascular surgery

Melissa D. Shah, MD, is recognized by Continental Who's Who

Retrieved on: 
Monday, January 16, 2023

ALBANY, N.Y., Jan. 16, 2023 /PRNewswire/ -- Melissa D. Shah, MD, is being recognized by Continental Who's Who as a Top Pinnacle Professional for her contributions as a Vascular Surgeon.

Key Points: 
  • ALBANY, N.Y., Jan. 16, 2023 /PRNewswire/ -- Melissa D. Shah, MD, is being recognized by Continental Who's Who as a Top Pinnacle Professional for her contributions as a Vascular Surgeon.
  • She completed her residency in General Surgery at Boston Medical Center in 2010 and a Fellowship in Vascular Surgery at Albany Medical Center in 2012.
  • She is board-certified in Vascular Surgery and General Surgery by the American Board of Surgery.
  • In her spare time, Dr. Shah enjoys spending time with her five-year-old Pomeranian and following Formula One automobile racing.

The Worldwide Point of Care Ultrasound System Industry is Expected to Reach $1.94 Billion by 2027: Multiple Uses Associated with Point of Care Ultrasounds Such as Therapeutics Drives Growth - ResearchAndMarkets.com

Retrieved on: 
Tuesday, January 17, 2023

The Global Point of Care Ultrasound System Market is estimated to be USD 1.3 Bn in 2022 and is expected to reach USD 1.94 Bn by 2027, growing at a CAGR of 8.29%.

Key Points: 
  • The Global Point of Care Ultrasound System Market is estimated to be USD 1.3 Bn in 2022 and is expected to reach USD 1.94 Bn by 2027, growing at a CAGR of 8.29%.
  • The report presents a detailed Ansoff matrix analysis for the Global Point of Care Ultrasound System Market.
  • The report offers a comprehensive evaluation of the Global Point of Care Ultrasound System Market.
  • The Global Point of Care Ultrasound System Market is segmented based on Mobility, Type, Application, End-Users, and Geography.

Prytime Medical Announces Appointment of New Chief Medical Officer

Retrieved on: 
Tuesday, November 8, 2022

SAN ANTONIO, Nov. 8, 2022 /PRNewswire-PRWeb/ -- Prytime Medical Inc - The REBOA Company™, the leading innovator and global provider of lifesaving REBOA products for noncompressible truncal hemorrhage (NCTH), today announced the hiring of Chief Medical Officer, Jeffrey H. Lawson, M.D., Ph.D.

Key Points: 
  • SAN ANTONIO, Nov. 8, 2022 /PRNewswire-PRWeb/ -- Prytime Medical Inc - The REBOA Company, the leading innovator and global provider of lifesaving REBOA products for noncompressible truncal hemorrhage (NCTH), today announced the hiring of Chief Medical Officer, Jeffrey H. Lawson, M.D., Ph.D.
    "The new technology that Prytime Medical has recently developed was designed specifically to aid in resuscitation and the management of non-compressible hemorrhage" said Dr. Jeff Lawson.
  • "Prytime Medical has fundamentally changed its overall strategy," said David Spencer CEO.
  • As a medical technology veteran, Dr. Lawson has served as CMO, President and Chief Executive Officer at Humacyte, Inc.
  • Prytime Medical Devices, Inc. is an innovative medical device company that designs, develops, and commercializes minimally invasive solutions for hemorrhage control.

Elizabeth A. Colaiuta, MD, is recognized by Continental Who's Who

Retrieved on: 
Wednesday, August 31, 2022

Inspired by her mother who was a nurse, Dr. Colaiuta was drawn to the medical field from a young age.

Key Points: 
  • Inspired by her mother who was a nurse, Dr. Colaiuta was drawn to the medical field from a young age.
  • As a practicing Vascular Surgeon since 1997, she has been helping patients in the Berwyn, IL, area for more than 15 years.
  • She completed a residency at Ascension Providence Hospital and a Vascular Surgery Fellowship at Wayne State University.
  • As a result of her education and training, the doctor is board-certified in Vascular Surgery by the American Board of Surgery (ABS).

Melissa D. Shah, MD is recognized by Continental Who's Who

Retrieved on: 
Monday, August 15, 2022

ALBANY, N.Y., Aug. 15, 2022 /PRNewswire/ -- Melissa D. Shah, MD, is being recognized by Continental Who's Who as a Trusted Healthcare Professional for her outstanding work as a Vascular Surgeon and in acknowledgment of her excellence at Albany Med Vascular Group.

Key Points: 
  • ALBANY, N.Y., Aug. 15, 2022 /PRNewswire/ -- Melissa D. Shah, MD, is being recognized by Continental Who's Who as a Trusted Healthcare Professional for her outstanding work as a Vascular Surgeon and in acknowledgment of her excellence at Albany Med Vascular Group.
  • A highly trained expert in her field, Dr. Shah has practiced at Albany Med Vascular Group for over 20 years.
  • Co-founded by Dr. Shah's father, the medical clinic is the largest provider of vascular surgery in the northeastern United States.
  • Today, many procedures pioneered by the Albany Med Vascular Group team are considered standard of care.

Sourabh Mukherjee, MD is recognized by Continental Who's Who

Retrieved on: 
Tuesday, June 28, 2022

HATTIESBURG, Miss., June 28, 2022 /PRNewswire/ -- Sourabh Mukherjee, MD, is being recognized by Continental Who's Who as a Top Healthcare Professional for his distinguished career in Vascular Surgery and in acknowledgment of his work with Hattiesburg Clinic Vascular Specialists.

Key Points: 
  • HATTIESBURG, Miss., June 28, 2022 /PRNewswire/ -- Sourabh Mukherjee, MD, is being recognized by Continental Who's Who as a Top Healthcare Professional for his distinguished career in Vascular Surgery and in acknowledgment of his work with Hattiesburg Clinic Vascular Specialists.
  • In his practice, he utilizes a combination of therapies, including minimally invasive outpatient procedures and open surgery, depending on the patient's individual medical needs.
  • He completed a Residency in General Surgery and a Fellowship in Vascular Surgery at the University of Tennessee Health Science Center.
  • Dr. Mukherjee is an active member of the American Medical Association and the Society for Vascular Surgery, among his professional affiliations.

Elizabeth A. Colaiuta, MD, is being recognized by Continental Who's Who

Retrieved on: 
Tuesday, April 26, 2022

Inspired by her mother, who was a nurse, Dr. Colaiuta was drawn to the medical field from a young age.

Key Points: 
  • Inspired by her mother, who was a nurse, Dr. Colaiuta was drawn to the medical field from a young age.
  • As a practicing Vascular Surgeon since 1997, she has been helping patients in the Berwyn, IL, area for more than 23 years.
  • After graduating from Tower Hill School, Dr. Colaiuta attended the American University of the Caribbean, where she earned a Medical Degree.
  • As a result of her education and training, the doctor is board-certified in Vascular Surgery by the American Board of Surgery (ABS).

NRMP Delivers a Strong Match to Thousands of Residency Applicants and Programs

Retrieved on: 
Friday, March 18, 2022

WASHINGTON, March 18, 2022 /PRNewswire/ -- Today the National Resident Matching Program® (NRMP®) celebrates Match Day with the applicants, medical schools, and residency training programs participating in the 2022 Main Residency Match®. Match Day is when domestic and international medical school students and graduates learn in which U.S. residency programs they will train. Match Day marks the end of Match Week and is a widely embraced, ceremonial opportunity for participants to join friends, family, and peers and reflect on their accomplishments as they begin the transition to careers as young physicians.

Key Points: 
  • WASHINGTON, March 18, 2022 /PRNewswire/ --Today the National Resident Matching Program(NRMP) celebrates Match Day with the applicants, medical schools, and residency training programs participating in the 2022 Main Residency Match.
  • Match Day is when domestic and international medical school students and graduates learn in which U.S. residency programs they will train.
  • "The NRMP is honored to have delivered another strong Match for the many applicants pursuing their dreams of becoming physicians.
  • Applicants who did not match to a residency position participated in the NRMP Match Week Supplemental Offer and Acceptance Program (SOAP) to obtain an unfilled position.

Implantica Taps Former Medtronic Executive Paul Mead for COO Role

Retrieved on: 
Tuesday, February 1, 2022

At Medtronic, Paul held positions of increasing responsibility based in the United States, Asia Pacific and then Europe as part of the Cardiovascular Group.

Key Points: 
  • At Medtronic, Paul held positions of increasing responsibility based in the United States, Asia Pacific and then Europe as part of the Cardiovascular Group.
  • "With Paul, one of the top executives of Medtronic is leaving one of the world's largest and most successful med-tech companies to join Implantica.
  • I am delighted to have such a highly competent senior executive, top leader and rising star from Medtronic joining Implantica and am very pleased to welcome Paul to our management team," said Peter Forsell, CEO of Implantica.
  • "I am excited to join Implantica and take on the role of COO to help build this company and realize Peter's vision.

Argon Medical Launches Novel Innovations for Portal Vein Access Procedures

Retrieved on: 
Tuesday, November 2, 2021

The SCORPION Portal Vein Access Series addresses the common challenges physicians encounter when placing a Transjugular Intrahepatic Portosystemic Shunt (TIPS) or conducting other portal vein access procedures.

Key Points: 
  • The SCORPION Portal Vein Access Series addresses the common challenges physicians encounter when placing a Transjugular Intrahepatic Portosystemic Shunt (TIPS) or conducting other portal vein access procedures.
  • The Scorpion Portal Vein Access Series utilizes a patented curve-in-curve system to offer physicians 360-degree range of motion with the needle or stylet used to access the portal vein.
  • said George Leondis, CEO of Argon Medical
    The Scorpion Portal Vein Access sets are currently available in the United States.
  • To learn more about the SCORPION Portal Vein Access Series, visit www.argonmedical.com/scorpion
    Argon Medical is a global manufacturer of specialty medical products, headquartered in Frisco, Texas.